Ginsenoside CK Protects Rat Livers by Activating PPARγ and CPT1A Pathways
Ginsenoside CK attenuates nonalcoholic fatty liver disease in preclinical rodent and cell models by activating the PPARγ and CPT1A signaling ...
Ginsenoside CK attenuates nonalcoholic fatty liver disease in preclinical rodent and cell models by activating the PPARγ and CPT1A signaling ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.